"Hepatitis B e Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G.
| Descriptor ID |
D006513
|
| MeSH Number(s) |
D23.050.327.495.500.469
|
| Concept/Terms |
Hepatitis B e Antigens- Hepatitis B e Antigens
- Hepatitis Be Antigens
- Antigens, Hepatitis Be
- Be Antigens, Hepatitis
- e Antigens
- Antigens, e
- HBeAg
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis B e Antigens".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis B e Antigens".
This graph shows the total number of publications written about "Hepatitis B e Antigens" by people in this website by year, and whether "Hepatitis B e Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 1 | 2 |
| 2003 | 1 | 1 | 2 |
| 2004 | 0 | 2 | 2 |
| 2008 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hepatitis B e Antigens" by people in Profiles.
-
Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B. J Hepatol. 2008 May; 48(5):728-35.
-
Functional analysis of complex hepatitis B virus variants associated with development of liver cirrhosis. Gastroenterology. 2006 Sep; 131(3):765-80.
-
Predictors of virologic response to Lamivudine treatment in children with chronic hepatitis B infection. Pediatr Infect Dis J. 2004 May; 23(5):441-5.
-
Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus. Gastroenterology. 2004 Jan; 126(1):81-90.
-
Durability of serologic response after lamivudine treatment of chronic hepatitis B. Hepatology. 2003 Apr; 37(4):748-55.
-
Histological outcome during long-term lamivudine therapy. Gastroenterology. 2003 Jan; 124(1):105-17.
-
Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B. Hepatology. 2002 Jul; 36(1):186-94.
-
Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med. 2002 May 30; 346(22):1706-13.
-
Amplification of full-length hepatitis B virus genomes from samples from patients with low levels of viremia: frequency and functional consequences of PCR-introduced mutations. J Clin Microbiol. 1998 Feb; 36(2):531-8.